Waits and Measures

Lehmann, Ray
February 2009
Best's Review;Feb2009, Vol. 109 Issue 10, p40
Trade Publication
The article discusses the insurance regulatory reform proposal in the U.S. Few industry advocates are prepared to predict easy passage for legislation revamping regulation of the surplus lines insurance market in the Congress. It is noted that the key would be whether there would be enough time when the committees of jurisdiction are taking up broader regulatory review and issues of macroeconomic significance. It cites the economic crisis as the barrier to the approval of the legislation.


Related Articles

  • SMART Free Market Plan Faces Uphill Battle. Tuckey, Steve // National Underwriter / P&C;5/30/2005, Vol. 109 Issue 21, p8 

    This article reports that members of the U.S. Congress are racing through a public input process aimed at getting at least some version of the State Modernization and Regulation Transparency Act (SMART) on the floor this year. The bill is tentively set for introduction in the House by mid...

  • A Full Financial Agenda for Legislators. Heller, Michelle // American Banker;10/18/2005, Vol. 170 Issue 200, p4 

    Reports that congressional committees are scheduled to consider deposit insurance, regulatory relief, derivatives growth, and possibly data security legislation next week. Debate in the Senate about a government funding bill that contains a provision that would permanently block the Treasury...

  • Congress should pass insurance reform bills.  // Business Insurance;6/2/2008, Vol. 42 Issue 22, p8 

    The article comments on two pending insurance legislation, which the author says, ought to be resolved quickly by the U.S. Congress. The first is the Nonadmitted and Reinsurance Reform Act, which streamlines regulation of the nonadmitted insurance market and reinsurers. The other is the...

  • Both Chambers Work on 9/11 Legislation. Gorman, Siobhan; Smallen, Jill; Mitchell, Charlie // National Journal;10/2/2004, Vol. 36 Issue 40, p2985 

    Reports on the continuing debates in the U.S. House and the Senate over their respective intelligence reform bills, which are meant to implement the recommendations of the 9/11 commission. Support for the Senate bill by the administration; Decision of Republican House leaders to oppose...

  • SMART Takes Back Seat To TRIA. Postal, Arthur D. // National Underwriter / P&C;7/25/2005, Vol. 109 Issue 28, p21 

    Reports on key controversies pertaining to Congressional debates on the extension of the Terrorism Risk Insurance Act that may delay the introduction of the SMART regulatory reform bill for the insurance industry in the U.S. Agreement over the introduction of an amendment to SMART that would...

  • A Balanced Approach to Insurance Regulation Reform. Myers Jr., Robert H. // Risk Management (00355593);Feb93, Vol. 40 Issue 2, p14 

    The article presents an update on the status of insurance regulation in the U.S. in 1993. The mood in the nation's capital is one of eager anticipation. For the first time in 12 years, the Democratic Party controls the White House and both houses of Congress. The administration of U.S. President...

  • SBC Still Divided Over GSEs.  // National Mortgage News;4/30/2007, Vol. 31 Issue 31, p21 

    The article reports on the move of Senate Banking Committee leaders to wait the House to pass the Government-Sponsored Enterprises (GSE) regulatory reform bill to settle the committee disputes for past 4 years in the U.S. According to Senator Mel Martinez, Republican-Florida, the Congress must...

  • Statement on Senate Action on Financial Regulatory Reform Legislation. Obama, Barack H. // Daily Compilation of Presidential Documents;4/26/2010, Special section p1 

    The article presents a short statement regarding the U.S. Senate action on financial regulatory reform legislation given by U.S. President Barack Obama on April 26, 2010. In his statement, President Obama expressed his disappointment with the Senate Republicans' vote to disallow the public...

  • The Anatomy of the Changing Pharmaceutical Supply Chain. Arnum, Patricia Van // Pharmaceutical Technology;Aug2008 Supplement, p56 

    The article examines the proposed legislative and regulatory reforms and actions taken by the U.S. Food and Drug Administration (FDA) to improve drug-import safety in the country. The reforms and actions arose after FDA's process for inspecting foreign drug-manufacturing facilities were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics